Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Q4 Revenue will be at least $11.3 million, representing 45% growth over prior year 2016 Revenue will be at least $41.0 million, representing 50% growth over prior year ALACHUA, Fla., Jan. 09, 2017 ...
-
ALACHUA, Fla., Jan. 05, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the appointment of...
-
ALACHUA, Fla., Jan. 03, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced its participation at the...
-
Marine Veteran’s Arm Saved from Amputation Following Severe Battle Injuries Promoting awareness of nerve injuries and tissue donation at the Tournament of Roses Parade ALACHUA, Fla., Dec. 14,...
-
ALACHUA, Fla., Nov. 21, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced the commercial release...
-
ALACHUA, Fla., Nov. 17, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej,...
-
ALACHUA, Fla., Nov. 15, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
-
ALACHUA, Fla., Nov. 02, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced financial results for...
-
ALACHUA, Fla., Oct. 26, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
-
ALACHUA, Fla., Oct. 19, 2016 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that...